Q3 2026 Holdings
Filed 2026-11-03 | 58 holdings | $515.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tesla Inc(TSLA) | COM | 88160R101 | $79.8M | 225,000 | 15.5% |
| Shopify Inc(SHOP) | CL A SUB VTG SHS | 82509L107 | $45.2M | 305,000 | 8.8% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $37.9M | 62,000 | 7.4% |
| Space Exploration Techn Corp(SPCX) | CLASS A COM STK | 84615Q103 | $37.7M | 250,000 | 7.3% |
| Palantir Technologies Inc(PLTR) | CL A | 69608A108 | $37.4M | 200,000 | 7.3% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $34.9M | 140,000 | 6.8% |
| Cerebras Systems Inc(CBRS) | COM CL A | 15675D103 | $19.7M | 111,000 | 3.8% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $18.5M | 81,000 | 3.6% |
| Spotify Technology S A(SPOT) | SHS | L8681T102 | $16.1M | 33,000 | 3.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $15.6M | 349,003 | 3.0% |
| Iren Limited(IREN) | ORDINARY SHARES | Q4982L109 | $15.1M | 370,150 | 2.9% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $14.1M | 215,818 | 2.7% |
| Lemonade Inc(LMND) | COM | 52567D107 | $12.2M | 270,259 | 2.4% |
| Opendoor Technologies Inc(OPEN) | COM | 683712103 | $12.2M | 5,140,904 | 2.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $10.9M | 48,400 | 2.1% |
| Nebius Group N.V.(NBIS) | SHS CLASS A | N97284108 | $9.4M | 40,000 | 1.8% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $9.1M | 5,467,149 | 1.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $8.8M | 333,193 | 1.7% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $7.9M | 42,944 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.9M | 89,151 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.2M | 216,197 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.1M | 20,607 | 1.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $4.8M | 229,857 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.5M | 75,000 | 0.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.4M | 107,915 | 0.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.7M | 26,200 | 0.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.5M | 233,037 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.3M | 9,970 | 0.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $3.2M | 32,100 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.0M | 166,605 | 0.6% |
| Ambev SA(ABEV) | SPONSORED ADR | 02319V103 | $2.9M | 989,723 | 0.6% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.7M | 48,974 | 0.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $2.3M | 208,512 | 0.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $2.2M | 91,282 | 0.4% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $1.7M | 23,643 | 0.3% |
| B2gold Corp(BTG) | COM | 11777Q209 | $1.4M | 265,505 | 0.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $1.3M | 90,110 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.1M | 232,900 | 0.2% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $1.1M | 155,000 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $981.9K | 414,311 | 0.2% |
| Autolus Therapeutics LTD(AUTL) | SPON ADS | 05280R100 | $910.8K | 469,490 | 0.2% |
| Transocean LTD(RIG) | REGISTERED SHS | H8817H100 | $815.9K | 155,699 | 0.2% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $768.5K | 4,064 | 0.1% |
| Lululemon Athletica Inc(LULU) | COM | 550021109 | $675.5K | 7,023 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $642.1K | 244,146 | 0.1% |
| NOV Inc(NOV) | COM | 62955J103 | $637.8K | 34,050 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $523.9K | 155,000 | 0.1% |
| Sandridge Energy Inc(SD) | COM NEW | 80007P869 | $523.3K | 38,792 | 0.1% |
| NU Hldgs LTD(NU) | ORD SHS CL A | G6683N103 | $483.2K | 38,168 | 0.1% |
| Seabridge Gold Inc(SA) | COM | 811927102 | $401.6K | 14,172 | 0.1% |